Stockscreener 앱 받기
73.00
1.00%
-0.7397
시간 외 거래:
73.24
0.2433
+0.33%
전일 마감가:
$73.74
열려 있는:
$73.02
하루 거래량:
1,063
Relative Volume:
0.34
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.04%
1개월 성능:
+1.51%
6개월 성능:
+25.46%
1년 성능:
+13.78%
1일 변동 폭
$73.00
$73.67
1주일 범위
$72.81
$74.63
52주 변동 폭
$48.65
$74.76
Virtus Lifesci Biotech Products Etf Stock (BBP) Company Profile
BBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBP
Virtus Lifesci Biotech Products Etf
|
73.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
331.74 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
675.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
678.81 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
251.12 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
619.25 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Products Etf 주식(BBP)의 최신 뉴스
Will Virtus LifeSci Biotech Products ETF stock issue positive guidancePortfolio Growth Summary & Community Shared Stock Ideas - newser.com
How Virtus LifeSci Biotech Products ETF stock performs in easing cyclesGap Up & Risk Controlled Stock Alerts - newser.com
Why Virtus LifeSci Biotech Products ETF stock stays undervaluedJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Biotech ETFs Hovering Around a 52-Week: Here's Why - Yahoo Finance
Price-Driven Insight from (BBP) for Rule-Based Strategy - news.stocktradersdaily.com
Is Virtus LifeSci Biotech Products ETF stock ideal for retirement investorsMarket Risk Report & Reliable Price Breakout Signals - newser.com
Is Virtus LifeSci Biotech Products ETF stock a top pick for value investorsTrade Entry Report & Safe Capital Growth Plans - newser.com
Biotech ETFs Bounce Back in 2025: Here's Why - Nasdaq
Entry Recap: Can Virtus LifeSci Biotech Products ETF stock beat analyst consensus - Trung tâm Dự báo KTTV quốc gia
LYX.HONG KONG(HSI)U.ETF D (LYME.HM) stock price, news, quote and history - Yahoo
TD ACTIVE GLOBAL ENHANCED DIVID (TGED.NE) company profile and facts - Yahoo
D.S.ETF-D.DA.S.CP BULL 2X (DX3H.BE) interactive stock chart - Yahoo
iShares Core SPI ETF (CH) I (XMTG.DU) company profile and facts - Yahoo
ETFS LEV NAT GAS (ELVGF.PK) company profile and facts - Yahoo
iShares ESG Aware MSCI USA Small-Cap ETF (ESML.MX) interactive stock chart - Yahoo
D.S.ETF-D.D.HG.YLD BEA.2X (0DFA.DU) company profile and facts - Yahoo
Am.ETF-A.Core MSCI World U.ETFR (MWOE.DU) holdings - Yahoo
HanseMerkur Strat.chancenreichI (UI2F.DU) interactive stock chart - Yahoo
LIF-600 PER.+H. EOA (LPHG.DU) interactive stock chart - Yahoo
Innovator Equity Dual Directional 15 Buffer ETFOctober (DDFO) company profile and facts - Yahoo
Will Virtus LifeSci Biotech Clinical Trials stock return to pre crash levelsMarket Movers & Proven Capital Preservation Methods - newser.com
Contrarian Investing in US Stocks: These ETFs Are Timely Picks - NAI500
7 Contrarian ETFs to Buy Today | Investing - US News Money
How the (BBP) price action is used to our Advantage - news.stocktradersdaily.com
(BBP) Trading Advice - news.stocktradersdaily.com
N-CSRS: Others - 富途牛牛
(BBP) Investment Analysis and Advice - news.stocktradersdaily.com
Hor Kew (SGX:BBP): Sustained EPS Growth & Strategic Moves Signal Buying Opportunity - AInvest
How To Trade (BBP) - news.stocktradersdaily.com
(BBP) Long Term Investment Analysis - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
(BBP) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion - Benzinga
6 Best-Performing ETFs of Last Week - Yahoo Finance
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Leverage Shares 2X Long ARM Daily ETF (ARMG) stock price, news, quote and history - Yahoo
(BBP) On The My Stocks Page - news.stocktradersdaily.com
SBIO ETF: Betting On Medical Breakthroughs (NYSEARCA:SBIO) - Seeking Alpha
(BBP) Trading Signals - news.stocktradersdaily.com
Virtus Lifesci Biotech Products Etf (BBP) 재무 분석
Virtus Lifesci Biotech Products Etf (BBP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.30%
자본화:
|
볼륨(24시간):